[HTML][HTML] Cost-effectiveness analysis of direct oral anticoagulants vs. vitamin K antagonists in the elderly with atrial fibrillation: insights from the evidence in a real-world …
Y Wu, C Zhang, ZC Gu - Frontiers in Cardiovascular Medicine, 2021 - frontiersin.org
Background: In the clinical setting, the economic benefits of direct oral anticoagulants
(DOACs) in elderly patients with atrial fibrillation (AF) remain unclear. This study aimed to …
(DOACs) in elderly patients with atrial fibrillation (AF) remain unclear. This study aimed to …
[HTML][HTML] Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real …
Y Wu, C Zhang, ZC Gu - Frontiers in Cardiovascular Medicine, 2021 - ncbi.nlm.nih.gov
Background: In the clinical setting, the economic benefits of direct oral anticoagulants
(DOACs) in elderly patients with atrial fibrillation (AF) remain unclear. This study aimed to …
(DOACs) in elderly patients with atrial fibrillation (AF) remain unclear. This study aimed to …
Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real-World …
Y Wu, C Zhang, ZC Gu - Frontiers in cardiovascular …, 2021 - pubmed.ncbi.nlm.nih.gov
Background: In the clinical setting, the economic benefits of direct oral anticoagulants
(DOACs) in elderly patients with atrial fibrillation (AF) remain unclear. This study aimed to …
(DOACs) in elderly patients with atrial fibrillation (AF) remain unclear. This study aimed to …
Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real-World …
Y Wu, C Zhang, ZC Gu - Frontiers in Cardiovascular Medicine, 2021 - europepmc.org
Background: In the clinical setting, the economic benefits of direct oral anticoagulants
(DOACs) in elderly patients with atrial fibrillation (AF) remain unclear. This study aimed to …
(DOACs) in elderly patients with atrial fibrillation (AF) remain unclear. This study aimed to …
Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real-World …
Y Wu, C Zhang, ZC Gu - Frontiers in Cardiovascular Medicine, 2021 - cir.nii.ac.jp
抄録< jats: p>< jats: bold> Background:</jats: bold> In the clinical setting, the economic
benefits of direct oral anticoagulants (DOACs) in elderly patients with atrial fibrillation (AF) …
benefits of direct oral anticoagulants (DOACs) in elderly patients with atrial fibrillation (AF) …